Evaluation of the MOVE online exercise programme for young people aged 13-30.


Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
05 Jun 2023
Historique:
received: 02 11 2022
accepted: 14 04 2023
medline: 7 6 2023
pubmed: 5 6 2023
entrez: 5 6 2023
Statut: epublish

Résumé

To evaluate the MOVE exercise programme in supporting the recovery of young people affected by cancer. Participants in an 8-week exercise rehabilitation programme delivered online by cancer rehabilitation specialists completed self-reported questionnaires at baseline and after programme completion. Assessments included cancer-related fatigue (FACIT fatigue scale) and health-related quality of life (EORTC-QLC-30). Qualitative data were provided through written accounts of participant experiences and underwent content analysis. Seventy-one participants commenced the exercise rehabilitation programme and 57 completed the programme and provided data for analysis (63% female; median age 22 years). Statistically significant improvements were observed in post-programme scores for all measured outcomes (cancer-related fatigue, quality of life, physical functioning, role functioning, emotional functioning). Content analysis of written experiences generated ten unique codes. The highest frequency codes were enjoyment (n = 34), motivation (n = 14) and fitness (n = 13). These findings indicate feasibility of delivery, acceptability to patients and physical and psychological benefits of a personalised online exercise rehabilitation programme for young people living with and beyond cancer. Further research involving a control arm and long-term follow-up would be beneficial. These results support the inclusion of a personalised exercise programme as part of cancer rehabilitation for young people living with and beyond cancer.

Identifiants

pubmed: 37273014
doi: 10.1007/s00520-023-07758-8
pii: 10.1007/s00520-023-07758-8
pmc: PMC10240106
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

377

Informations de copyright

© 2023. The Author(s).

Références

Cancer. 2020 Aug 15;126(16):3768-3776
pubmed: 32538481
Nat Rev Clin Oncol. 2014 Oct;11(10):597-609
pubmed: 25113839
J Cancer Surviv. 2021 Apr;15(2):281-310
pubmed: 32930924
Cochrane Database Syst Rev. 2012 Nov 14;11:CD006145
pubmed: 23152233
Cancer. 2020 Jun 15;126(12):2731-2732
pubmed: 32441798
Acta Oncol. 2019 Dec;58(12):1676-1683
pubmed: 31241428
J Clin Oncol. 2020 Sep 1;38(25):2839-2848
pubmed: 32574114
Pediatr Blood Cancer. 2020 Jul;67(7):e28339
pubmed: 32386117
BMJ Open. 2015 Oct 01;5(10):e007953
pubmed: 26428330
Support Care Cancer. 2021 May;29(5):2653-2662
pubmed: 32970230
Health Qual Life Outcomes. 2003 Dec 16;1:79
pubmed: 14678568
Int J Environ Res Public Health. 2020 Jul 24;17(15):
pubmed: 32722265
J Med Internet Res. 2017 Sep 14;19(9):e322
pubmed: 28912116
J Pain Symptom Manage. 1997 Feb;13(2):63-74
pubmed: 9095563
Int J Nurs Stud. 2020 Nov;111:103707
pubmed: 32920423
BMC Cancer. 2020 Jul 28;20(1):697
pubmed: 32723357
J Pediatr Hematol Oncol. 2007 Jul;29(7):471-9
pubmed: 17609625
Epidemiol Rev. 2017 Jan 1;39(1):71-92
pubmed: 28453622
Medicine (Baltimore). 2020 May 29;99(22):e20427
pubmed: 32481443
J Natl Cancer Inst. 1993 Mar 3;85(5):365-76
pubmed: 8433390
Scand J Psychol. 2019 Dec;60(6):577-584
pubmed: 31503342
Support Care Cancer. 2020 Dec;28(12):5803-5812
pubmed: 32221668
BMC Cancer. 2020 Aug 20;20(1):787
pubmed: 32819304
J R Soc Med. 2013 Dec;106(12):482-91
pubmed: 23824330
Pediatr Blood Cancer. 2020 Sep;67(9):e28530
pubmed: 32589339
J Pain Symptom Manage. 2021 Jan;61(1):167-189.e14
pubmed: 32768552
Breast Cancer Res Treat. 2019 Jun;175(3):637-648
pubmed: 30915663
Eur J Cancer. 2022 Jul;170:209-235
pubmed: 35689897
Support Care Cancer. 2021 May;29(5):2613-2620
pubmed: 32964260
J Physiother. 2016 Apr;62(2):68-82
pubmed: 26996098
Semin Hematol. 1997 Jul;34(3 Suppl 2):13-9
pubmed: 9253779
Front Oncol. 2020 Sep 25;10:578888
pubmed: 33102236
Semin Oncol Nurs. 2020 Oct;36(5):151071
pubmed: 33008683

Auteurs

Ellie Barnes (E)

Queens Medical Centre, University of Nottingham School of Medicine, Nottingham, NG7 2UH, UK.

Gemma Hillier-Moses (G)

MOVE Charity, 21 Cleeve Mount, Registered Charity Number 1165675, Loughborough, LE11 4SD, UK.

Helen Murray (H)

MOVE Charity, 21 Cleeve Mount, Registered Charity Number 1165675, Loughborough, LE11 4SD, UK.

Clare Stevinson (C)

School of Sport, Exercise and Health Sciences, Loughborough University, Loughborough, LE11 3TU, UK.

Hester A Franks (HA)

Centre for Cancer Sciences, Translational Medical Sciences, Biodiscovery Institute, University of Nottingham, Nottingham, NG7 2RD, UK. hester.franks@nottingham.ac.uk.
Department of Oncology, Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Hucknall Road, Nottingham, NG5 1PB, UK. hester.franks@nottingham.ac.uk.

Lucy Gossage (L)

MOVE Charity, 21 Cleeve Mount, Registered Charity Number 1165675, Loughborough, LE11 4SD, UK.
Department of Oncology, Nottingham University Hospitals NHS Trust, Nottingham City Hospital, Hucknall Road, Nottingham, NG5 1PB, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH